Skip to main content
. 2019 Dec 3;14:280. doi: 10.1186/s13023-019-1256-5

Table 2.

Pre- and post-geneMDD diagnosis

Pre-geneMDD Post-geneMDD
Pulmonary diagnosis
 IPF 27 (28%) 25 (26%)
 Unclassifiable 34 (36%) 29 (30%)
 Alternative ILD diagnosis 18 (19%) 22 (23%)
 No ILD 16 (16%) 18 (19%)
Genetic diagnosis
 VUS 22 5
 VUSD or pathogenic 44 61

VUS variant of unknown significance, VUSD working diagnosis of damaging variant

Bold data signifies Data ate N (%)